CA Patent

CA3118172A1 — Halogenated salicylanilides for treating the symptoms of dermatitis

Assigned to Union Therapeutics AS · Expires 2020-05-07 · 6y expired

What this patent protects

The present invention relates to halogenated salicylanilides for use in the treatment of dermatitis in a non-human subject, for example canine or feline atopic dermatitis.

USPTO Abstract

The present invention relates to halogenated salicylanilides for use in the treatment of dermatitis in a non-human subject, for example canine or feline atopic dermatitis.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CA3118172A1
Jurisdiction: CA
Classification: —
Expires: 2020-05-07
Drug substance claim: No
Drug product claim: No
Assignee: Union Therapeutics AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.